KPWHRI researchers analyzed data from more than 640,000 vaccine doses to understand risk of severe reactions.
KPWHRI receives $10 million to continue vaccine effectiveness research for flu, COVID-19, and other respiratory diseases.
Encouraging immune-response and safety data emerge from preliminary human test of genetically attenuated parasite vaccine.
Annie Hoopes, MD, MPH, shares insights from an ACT Center study on integrating adolescent mental health in primary care.
Please send comments or suggestions to Sophie Ramsey at Sophia.X.Ramsey@kp.org.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.